CD80 Rabbit Polyclonal Antibody

CD80 Rabbit Polyclonal Antibody

To Order Contact Us Below:

    CD80 Rabbit pAb
    A16039-200ul 200 ul
    EUR 550.8

    CD80 Rabbit pAb
    A16039-20ul 20 ul
    EUR 219.6

    CD80 Rabbit pAb
    A16039-50ul 50 ul
    EUR 267.6

    CD80 Rabbit mAb
    A19025-100ul 100 ul
    EUR 492

    CD80 Rabbit mAb
    A19025-200ul 200 ul
    EUR 685.2

    CD80 Rabbit mAb
    A19025-20ul 20 ul
    EUR 265.2

    CD80 Rabbit mAb
    A19025-50ul 50 ul
    EUR 344.4

    CD80 Antibody
    1-CSB-PA129040
    • EUR 266.40
    • EUR 234.00
    • 100ug
    • 50ug
    Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC-p:1:50-300, ELISA:1:10000-20000

    CD80 Antibody
    1-CSB-PA130815
    • EUR 380.40
    • EUR 292.80
    • 100ul
    • 50ul
    Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100

    CD80 Antibody
    1-CSB-PA277650
    • EUR 380.40
    • EUR 292.80
    • 100ul
    • 50ul
    Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

    CD80 Antibody
    1-CSB-PA004959GA01HU
    • EUR 716.40
    • EUR 399.60
    • 150ul
    • 50ul
    Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB

    CD80 Antibody
    DF7682 200ul
    EUR 420

    CD80 antibody
    70R-35657 100 ug
    EUR 418.8
    Description: Rabbit polyclonal CD80 antibody

    CD80 Antibody
    49409-100ul 100ul
    EUR 399.6

    CD80 Antibody
    49409-50ul 50ul
    EUR 286.8

    CD80 antibody
    70R-13908 100 ug
    EUR 386.4
    Description: Affinity purified Mouse polyclonal CD80 antibody

    CD80 Antibody
    37436-100ul 100ul
    EUR 302.4

    CD80 antibody
    10R-6436 100 ug
    EUR 282
    Description: Armenian Hamster monoclonal CD80 antibody

    CD80 antibody
    10R-6437 100 ug
    EUR 230.4
    Description: Mouse monoclonal CD80 antibody

    CD80 antibody
    10R-6844 100 ul
    EUR 829.2
    Description: Mouse monoclonal CD80 antibody

    CD80 antibody
    10R-7741 500 ug
    EUR 678
    Description: Rat monoclonal CD80 antibody

    CD80 antibody
    10R-1912 100 ul
    EUR 483.6
    Description: Mouse monoclonal CD80 antibody

    CD80 antibody
    10R-CD80bMS 500 ug
    EUR 444
    Description: Rat monoclonal CD80 antibody

    CD80 antibody
    10R-3627 100 ul
    EUR 829.2
    Description: Mouse monoclonal CD80 antibody

    CD80 antibody
    10R-3628 100 ul
    EUR 829.2
    Description: Mouse monoclonal CD80 antibody

    CD80 antibody
    10R-3629 100 ul
    EUR 829.2
    Description: Mouse monoclonal CD80 antibody

    CD80 antibody
    10R-3630 100 ul
    EUR 829.2
    Description: Mouse monoclonal CD80 antibody

    CD80 antibody
    10R-3631 100 ul
    EUR 829.2
    Description: Mouse monoclonal CD80 antibody

    CD80 antibody
    10R-3632 100 ul
    EUR 829.2
    Description: Mouse monoclonal CD80 antibody

    CD80 antibody
    10R-3634 100 ul
    EUR 829.2
    Description: Mouse monoclonal CD80 antibody

    CD80 antibody
    10R-3635 100 ul
    EUR 829.2
    Description: Mouse monoclonal CD80 antibody

    CD80 Antibody
    ABD7682 100 ug
    EUR 525.6

    CD80 Antibody
    ABD8145 100 ug
    EUR 525.6

    CD80 Antibody
    8679-002mg 0.02 mg
    EUR 206.18
    Description: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody
    8679-01mg 0.1 mg
    EUR 523.7
    Description: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 antibody
    PAab09813 100 ug
    EUR 463.2

    CD80 Antibody
    R30433 100 ug
    EUR 419

    CD80 Antibody
    R30434 100 ug
    EUR 419

    CD80 Antibody
    R34234-100UG 100 ug
    EUR 399

    CD80 Antibody
    RQ4248 100 ug
    EUR 419

    CD80 Antibody
    V8234-100UG 100 ug
    EUR 499
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V8234-20UG 20 ug
    EUR 219
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V8234SAF-100UG 100 ug
    EUR 499
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V8522-100UG 100 ug
    EUR 499
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    RQ6838 100ug
    EUR 419
    Description: Cluster of Differentiation 80 (also CD80 and B7-1) is a protein found on activated B cells and monocytes that provides a costimulatory signal necessary for T cell activation and survival. It is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD80 works in tandem with CD86 to prime T cells. The CD80 genes encode B7-1 which are structurally similar members of the immunoglobulin superfamily expressed on a variety of hematopoietic cell types.

    CD80 Antibody
    F48980-0.08ML 0.08 ml
    EUR 165

    CD80 Antibody
    F48980-0.4ML 0.4 ml
    EUR 379

    CD80 Antibody
    V7382-100UG 100 ug
    EUR 499
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V7382-20UG 20 ug
    EUR 219
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V7382IHC-7ML 7 ml
    EUR 499
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V7382SAF-100UG 100 ug
    EUR 499
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V7498-100UG 100 ug
    EUR 499
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V7498-20UG 20 ug
    EUR 219
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V7498SAF-100UG 100 ug
    EUR 499
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V3297-100UG 100 ug
    EUR 499
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V3297-20UG 20 ug
    EUR 219
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V3297SAF-100UG 100 ug
    EUR 499
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V8522-20UG 20 ug
    EUR 219
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    CD80 Antibody
    V8522SAF-100UG 100 ug
    EUR 499
    Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    Polyclonal CD80 Antibody (internal region)
    APR11032G 0.1 mg
    EUR 580.8
    Description: A polyclonal antibody raised in Goat that recognizes and binds to Human CD80 (internal region). This antibody is tested and proven to work in the following applications:

    Rabbit T- lymphocyte activation antigen CD80, CD80 ELISA KIT
    ELI-06510Ra 96 Tests
    EUR 1113.6

    Anti-CD80/B7 1 Rabbit Monoclonal Antibody
    M00196 100ug/vial
    EUR 476.4
    Description: Rabbit Monoclonal CD80/B7 1 Antibody. Validated in IHC, WB and tested in Human.

    CD80
    80A-100T 100 test
    EUR 450

    CD80
    80F-100T 100 test
    EUR 372

    CD80
    80PE-100T 100 test
    EUR 762

    CD80
    MO80A(V100) 100 ug
    EUR 60

    CD80
    MO80A(V25) 25 ug
    EUR 60

    CD80
    MO80B(V100) 100 ug
    EUR 60

    CD80
    MO80B(V25) 25 ug
    EUR 60

    CD80
    MO80CFB(V100) 100 ug
    EUR 60

    CD80
    MO80CFB(V25) 25 ug
    EUR 60

    CD80
    MO80F(V100) 100 ug
    EUR 60

    CD80
    MO80F(V25) 25 ug
    EUR 60

    CD80
    MO80F(V500) 500 ug
    EUR 60

    CD80
    MO80PE(V100) 100 ug
    EUR 60

    CD80
    MO80PE(V25) 25 ug
    EUR 60

    CD80
    MO80PP(V100) 100 ug
    EUR 60

    CD80
    MO80PP(V25) 25 ug
    EUR 60

    CD80
    MO80PP5.5(V100) 100 ug
    EUR 60

    CD80
    MO80PP5.5(V25) 25 ug
    EUR 60

    CD80
    MO80PU(V100) 100 ug
    EUR 60

    CD80
    MO80PU(V500) 500 ug
    EUR 60

    Polyclonal CD80 antibody - C-terminal region
    APR11033G 0.05mg
    EUR 633.6
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CD80 - C-terminal region. This antibody is tested and proven to work in the following applications:

    T-lymphocyte activation antigen CD80 (CD80) Antibody
    20-abx019054
    • EUR 410.40
    • EUR 109.20
    • 100 ug
    • 10 ug

    CD80 Conjugated Antibody
    C49409 100ul
    EUR 476.4

    anti- CD80 antibody
    FNab01500 100µg
    EUR 658.5
    Description: Antibody raised against CD80

    CD80 antibody (FITC)
    61R-1108 100 ug
    EUR 360
    Description: Armenian Hamster monoclonal CD80 antibody (FITC)

    CD80 antibody (PE)
    61R-1274 100 ug
    EUR 379.2
    Description: Mouse monoclonal CD80 antibody (PE)

    CD80 antibody (PE)
    61R-1275 100 ug
    EUR 424.8
    Description: Armenian Hamster monoclonal CD80 antibody (PE)

    CD80 antibody (PE)
    61R-1276 100 tests
    EUR 463.2
    Description: Mouse monoclonal CD80 antibody (PE)

    CD80 antibody (biotin)
    61R-1527 100 ug
    EUR 379.2
    Description: Mouse monoclonal CD80 antibody (biotin)

    CD80 antibody (biotin)
    61R-1528 100 ug
    EUR 340.8
    Description: Armenian Hamster monoclonal CD80 antibody (biotin)

    CD80 antibody (biotin)
    61R-1529 100 ug
    EUR 379.2
    Description: Mouse monoclonal CD80 antibody (biotin)

    CD80 antibody (allophycocyanin)
    61R-1743 100 ug
    EUR 548.4
    Description: Armenian Hamster monoclonal CD80 antibody (allophycocyanin)

    CD80 antibody (FITC)
    61R-CD80bHUFT 120 tests
    EUR 651.6
    Description: Mouse monoclonal CD80 antibody (FITC)

    CD80 antibody (Allophycocyanin)
    61R-CD80bMSAPC 100 ug
    EUR 522
    Description: Rat monoclonal CD80 antibody (Allophycocyanin)

    CD80 antibody (biotin)
    61R-CD80bMSBT 500 ug
    EUR 495.6
    Description: Rat monoclonal CD80 antibody (biotin)

    CD80 antibody (FITC)
    61R-CD80bMSFT 500 ug
    EUR 548.4
    Description: Rat monoclonal CD80 antibody (FITC)

    CD80 antibody (PE)
    61R-CD80bMSPE 200 ug
    EUR 548.4
    Description: Rat monoclonal CD80 antibody (PE)

    Hamster CD80 Antibody
    abx140014-01mg 0.1 mg
    EUR 343.2

    Anti-CD80 Antibody
    A00196-1 100ug/vial
    EUR 400.8

    Anti-CD80 Antibody
    PA1365 100ug/vial
    EUR 352.8

    Anti-CD80 Antibody
    PA1365-1 100ug/vial
    EUR 352.8

    anti- CD80 antibody
    FNab09813 100µg
    EUR 658.5
    Description: Antibody raised against CD80

    Anti-CD80 antibody
    PAab01500 100 ug
    EUR 463.2

    Anti-CD80 Antibody
    STJ500483 100 µg
    EUR 571.2

    Anti-CD80 antibody
    STJ16100188 100 µg
    EUR 483.6

    Anti-CD80 antibody
    STJ16100189 100 µg
    EUR 628.8

    Anti-CD80 antibody
    STJ16101125 100 µg
    EUR 424.8

    Anti-CD80 antibody
    STJ170002 100 µg
    EUR 409.2
    Description: The CD80 antigen (B7, BB1) recognizes a 60 kDa transmembrane glycoprotein, member of the immunoglobulin family. This molecule shares with CD86 the capability to be the ligand for two structurally similar molecules expressed on T lymphocytes, CD28 and CD152 (CTLA-4). CD80 antigen is expressed on in vitro activated B lymphocytes. It is not expressed on the majority of resting B cells from peripheral blood but identifies a subpopulation of B cells that has been previously activated. The antigen is also expressed by HTLV-1 transformed T cells activated monocytes, and constitutively on dendritic cells. CD80 binding provides costimulatory signals for T cell activation.

    Anti-CD80 antibody
    STJ72065 100 µg
    EUR 430.8

    Anti-CD80 antibody
    STJ118492 100 µl
    EUR 332.4

    CD80 Antibody [8G12]
    RF16041-002mg 0.02 mg
    EUR 229.7
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody [8G12]
    RF16041-01mg 0.1 mg
    EUR 594.26
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody [10A1]
    RF16042-002mg 0.02 mg
    EUR 229.7
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody [10A1]
    RF16042-01mg 0.1 mg
    EUR 594.26
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody [7A2]
    RF16043-002mg 0.02 mg
    EUR 229.7
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody [7A2]
    RF16043-01mg 0.1 mg
    EUR 594.26
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody [11D1]
    RF16044-002mg 0.02 mg
    EUR 229.7
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody [11D1]
    RF16044-01mg 0.1 mg
    EUR 594.26
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody [11C12]
    RF16045-002mg 0.02 mg
    EUR 229.7
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody [11C12]
    RF16045-01mg 0.1 mg
    EUR 594.26
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody [12D9]
    RF16046-002mg 0.02 mg
    EUR 229.7
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    CD80 Antibody [12D9]
    RF16046-01mg 0.1 mg
    EUR 594.26
    Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

    Anti-CD80 antibody
    STJ98977 200 µl
    EUR 236.4
    Description: Rabbit polyclonal to CD80.

    Anti-CD80 antibody
    STJ97938 100 µl
    EUR 280.8
    Description: Mouse monoclonal to CD80.

    CD80 Rabbit Polyclonal Antibody

    Scroll to Top